Lucy Therapeutics

Effective treatments for neurological disease start with the mitochondria

General Information
Company Name
Lucy Therapeutics
Founded Year
2017
Location (Offices)
Waltham, United States +1
Founders / Decision Makers
Number of Employees
15
Industries
-
Funding Stage
-
Social Media

Lucy Therapeutics - Company Profile

Lucy Therapeutics is a private biotech company focused on developing proprietary small molecule therapies and diagnostic biomarkers using knowledge mapping and mitochondrial expertise to identify and prosecute new targets at the nexus points of genetic, mitochondrial and environmental dysfunction for complex diseases. Our initial focus is on CNS diseases where disease progression is rarely tied to genetics alone and mitochondrial and environmental factors play a bigger role than has been previously thought. LucyTx has identified two separate targets with this approach - one for the orphan disease Rett Syndrome and another for Parkinson’s disease. Our targets have been validated as neuroprotective in multiple animal models and Development Candidates have been identified for both programs. LucyTx is pursuing financing to enter the clinic for these advanced programs.

Funding Rounds & Investors of Lucy Therapeutics (0)

View All

There is no investment information

Latest News of Lucy Therapeutics

View All

No recent news or press coverage available for Lucy Therapeutics.

Similar Companies to Lucy Therapeutics

View All
RiboNova, Inc. - Similar company to Lucy Therapeutics
RiboNova, Inc. Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset, we also have tRNA discovery.
Khondrion - Similar company to Lucy Therapeutics
Khondrion Bringing energy to life
Ixchel Pharma - Similar company to Lucy Therapeutics
Ixchel Pharma Pioneering the future of treatments for rare mitochondrial diseases with repurposed drug solutions.